Archive

Ivermectin for covid-19 – the highlights

Written by | 29 Jul 2023

Ivermectin is an effective antiviral agent with a long record of successful use in human and animal parasite infestations. Its value as part of the early treatment for […]

Ivermectin gathers pace in Europe

Written by | 31 Jan 2021

During the past week Slovakia became the first European country to give formal approval for the use of ivermectin for both prophylaxis and treatment of covid-19 patients. Ivermectin […]

Ivermectin meta-analysis – the implications

Written by | 27 Jan 2021

Dr Tess Lawrie, Director of the Evidence-based Medicine Consultancy Ltd, describes the implications of her recently-published meta-analysis of ivermectin trials for covid-19. Dr Lawrie is now trying to make an […]

Ivermectin meta-analysis – the findings

Written by | 26 Jan 2021

Dr Tess Lawrie, Director of the Evidence-based Medicine Consultancy Ltd, describes the key findings from her recently-published meta-analysis of ivermectin trials for covid-19. The first finding was that ivermectin […]

Ivermectin meta-analysis – the background

Written by | 25 Jan 2021

IMI interviewed Dr Tess Lawrie, Director of the Evidence-based Medicine Consultancy Ltd, to find out more about her recently-published meta-analysis of ivermectin trials for covid-19. The Evidence-based Medicine Consultancy […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.